Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kerstin Kellershohn"'
Autor:
Anne-Sophie Michallet, Melih Aktan, Wolfgang Hiddemann, Osman Ilhan, Peter Johansson, Kamel Laribi, Balkis Meddeb, Carol Moreno, João Raposo, Anna Schuh, Ali Ünal, Tom Widenius, Alf Bernhardt, Kerstin Kellershohn, Dimitri Messeri, Stuart Osborne, Véronique Leblond
Publikováno v:
Haematologica, Vol 103, Iss 4 (2018)
MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chlorambucil in fludarabine-ineligible patients with chronic lymphocytic leukemia. Patients received rituximab plus bendamustine or rituximab plus chlorambuci
Externí odkaz:
https://doaj.org/article/ffd24f20e50d48d1825a40285a4635a3
Autor:
Kamel Laribi, Osman Ilhan, Wolfgang Hiddemann, Dimitri Messeri, Anne-Sophie Michallet, Carol Moreno, Peter Johansson, Véronique Leblond, Ali Ünal, Anna Schuh, Alf Bernhardt, Melih Aktan, Tom Widenius, Balkis Meddeb, S. Osborne, João Raposo, Kerstin Kellershohn
Publikováno v:
Haematologica
HAEMATOLOGICA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
HAEMATOLOGICA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chlorambucil in fludarabine-ineligible patients with chronic lymphocytic leukemia. Patients received rituximab plus bendamustine or rituximab plus chlorambuci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a57c9756d1520679cc710d3f3170f7a7
https://avesis.erciyes.edu.tr/publication/details/e88a22f2-5c33-4f73-9fe0-1566c1bbd91a/oai
https://avesis.erciyes.edu.tr/publication/details/e88a22f2-5c33-4f73-9fe0-1566c1bbd91a/oai
Autor:
M. Reiser, Dietmar Reichert, Mark Hoesl, Dirk Meyer, Moritz Marquardt, Michael Koenigsmann, Andreas Schwarzer, Kathleen Jentsch-Ullrich, Wolf-Oliver Jordan, Kerstin Kellershohn, Steffen Dörfel, Manfred Hensel
Publikováno v:
European journal of haematology. 100(5)
Objectives This study was conducted to investigate the real-world effectiveness and tolerability of rituximab-containing chemoimmunotherapies, which have become the standard of care for chronic lymphocytic leukaemia (CLL), particularly for physically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1eeaa07a2e5679e3d1cd8c73f80361a
https://pubmed.ncbi.nlm.nih.gov/29393986
https://pubmed.ncbi.nlm.nih.gov/29393986
Autor:
Klaus Mohr, Elisabetta Barocelli, Kerstin Kellershohn, Simona Bertoni, Ulrike Holzgrabe, Mathias Muth, Marco De Amici, Clelia Dallanoce, Teresa Disingrini
Publikováno v:
Journal of Medicinal Chemistry. 49:366-372
A novel series of muscarinic receptor ligands of the hexamethonio-type was prepared which contained, on one side, the phthalimidopropane or 1,8-naphthalimido-2,2-dimethylpropane moiety typical for subtype selective allosteric antagonists and, on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc1dbe99317fae46c879fc7fed1eb3b
https://doi.org/10.1021/jm050769s
https://doi.org/10.1021/jm050769s
Autor:
Johannes Antony, Clelia Dallanoce, Klaus Mohr, Anna Kebig, Stefanie Prilla, Mathias Muth, Teresa Disingrini, Kerstin Kellershohn, Evi Kostenis, Eberhard Heller, Simona Bertoni, Hans-Dieter Höltje, Jasmin Schrobang, Ulrike Holzgrabe, Marco De Amici, Christian Tränkle, Marion Mohr-Andrä, Arthur Christopoulos, Elisabetta Barocelli
Publikováno v:
Monash University
Selective modulation of cell function by G protein-coupled receptor (GPCR) activation is highly desirable for basic research and therapy but difficult to achieve. We present a novel strategy toward this goal using muscarinic acetylcholine receptors a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ebab44df582cfab7fba2e0749168ddc
https://pubmed.ncbi.nlm.nih.gov/18842964
https://pubmed.ncbi.nlm.nih.gov/18842964